Luckwel Pharmaceuticals Inc. (OTCPK:LWEL) entered into subscription agreements with six individuals to issue an aggregate of 300,000 restricted shares par value $0.01 per share at a price per share of $0.40 for gross proceeds of $120,000 on April 20, 2021. The transaction is expected to close on April 29, 2021. The shares have been registered under the Securities Act of 1933. The transaction is pursuant to Regulation S.